By Michele Maatouk
Date: Tuesday 19 Mar 2024
LONDON (ShareCast) - (Sharecast News) - Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
Pfizer was planning to sell around 630m shares in a public offering but the size of the offering was increased to just over 790.5m.
Haleon sold 594m ordinary shares at £3.08 each and 196.5m American Depository Shares (ADR) at $7.85 each. It raised around £1.8bn and $1.5bn, respectively.
The maker of Sensodyne toothpaste and Panadol said it has also agreed to buy back 102.2m ordinary shares from Pfizer off-market for around £315m.
Email this article to a friend
or share it with one of these popular networks:
Currency | US Dollars |
Share Price | $ 24.51 |
Change Today | $ 0.28 |
% Change | 1.16 % |
52 Week High | $29.27 |
52 Week Low | $21.59 |
Volume | 40,101,861 |
Shares Issued | 5,667m |
Market Cap | $138,898m |
Beta | 0.45 |
RiskGrade | 102 |
Strong Buy | 4 |
Buy | 5 |
Neutral | 14 |
Sell | 0 |
Strong Sell | 1 |
Total | 24 |
Time | Volume / Share Price |
16:00 | 2,613,428 @ $24.51 |
15:59 | 1,400 @ $24.52 |
15:59 | 154 @ $24.52 |
15:59 | 344 @ $24.52 |
15:59 | 115 @ $24.51 |
You are here: research